NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS). The settlement provides for a fund of $4,650,000 to benefit class members. For the purposes of the settlement, the class is defined as: all persons and entities that purchased or otherwise acquired the publicly traded common stock of Adamas, between August 8, 2017 and March 4, 2019, both dates inclusive (the "Settlement Class Period"), and were damaged thereby.
If you are a class member as defined above, you may be entitled to a pro-rata share of the settlement fund. In order to receive a share of the settlement, you must file a claim form by August 28, 2024.
For more details on the settlement, including a copy of the claim form, please visit: https://zlk.com/settlement-form/?redirect=aHR0cHM6Ly96bGsuY29tL3NldHRsZW1lbnQvYWRhbWFzLXBoYXJtYWNldXRpY2Fscy1pbmMtc2V0dGxlbWVudA==&spr=536&wire=1&ticker=ADMS
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action. We are providing this information as a courtesy to remind class members of the claims deadline so they can file their forms in a timely fashion.
Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/
SOURCE: Levi & Korsinsky, LLP